I am a leading author and contributor on several financial websites, namely TalkMarkets, Seeking Alpha and INO.com. I cover a broad range of investment strategies; currency hedging, value, growth, options and dividend investing. I also cover long-term wealth creating strategies such as leveraging ...
more I am a leading author and contributor on several financial websites, namely TalkMarkets, Seeking Alpha and INO.com. I cover a broad range of investment strategies; currency hedging, value, growth, options and dividend investing. I also cover long-term wealth creating strategies such as leveraging 401ks, Roth IRAs and Health Savings Accounts (HSAs) to augment one's long-term investment approach. My area of emphasis is geared towards the overall healthcare industry (i.e. biotechnology, health insurers, large pharma, pharmacy benefit managers and pharmaceutical wholesalers) highlighting sector trends, political backdrop/current events, key developments and mergers and acquisitions. I authored a bi-monthly newsletter covering these topics in collaboration with INO.com. In partnership with INO.com, I author a bi-monthly newsletter service titled "Political Plays". In an effort to assist traders and investors to bridge the gap between Washington and Wall Street and provide actionable updates driven by political action. This is an apolitical newsletter assessing the potential impact of proposed and ongoing legislation across a broad range of industries occurring at the federal level. I am a biotechnology professional with a diverse scientific background and detailed knowledge in many therapeutic areas such as monoclonal antibodies and immunotherapies. I have a deep understanding of the clinical and regulatory aspects with respect to drug development and drug approvals. I have a personal interest in finance, investing and specifically options trading. My investment strategy is long-term/retirement oriented while exploring avenues to maximize wealth in retirement. My analyses are focused on individual stocks, sector trends and niche opportunities such as options trading.
less
Latest Comments
Visa’s Growth Slowdown Has Begun
I wrote a follow-up article on Seeking Alpha after its most recent earnings in which Visa only grew revenue by 9% which is a far cry from the double digit revenue increases over the past year-plus. I never short equities.
Disney: Fox Acquisition, Streaming And Tax Reform
Looking at Thor: Ragnarok, Coco and Star Wars in Q1 FY2018 and now Blank Panther which will be followed up by Infinity War, Incredibles 2, Ant Man and the Wasp and Star Wars: Solo. Then there Mulan, Aladdian and Lion King live-action films and Frozen 2 with more Marvel movies in 2019. The theme parks have been growing and once the Media Networks segment gets revived, it's off to the races.
Disney: Fox Acquisition, Streaming And Tax Reform
Agreed, throw in the Fox assets and these can be used to augment the Marvel Universe and theme parks.
IBB – Challenging 2016, Recovering 2017 And Resurgence In 2018
Thanks Dean! Appreciate the positive feedback.
Disney: Fox Acquisition, Streaming And Tax Reform
Look at the movie slate for 2018-2019, huge! Blank Panther posting $218 million opening, Infinity War, Ant Man and the Wasp, Incredibles 2, Star Wars: Solo, etc in the next few months.
Disney: Fox Acquisition, Streaming And Tax Reform
Hulu stake, ESPN streaming launching and OTT Disney offering in 2019 will be huge and transition the Media Networks segment to the digital age. Blank Panther just scored a record breaking opening with $218 million!